Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.07.2020 | Case report

Azithromycin/hydroxychloroquine/propofol

Hypoglycaemia and cardiotoxicities following off label use: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mercuro NJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) JAMA Cardiology : 2020. Available from: URL: /link?doi=10.1001/jamacardio.2020.1834 Mercuro NJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) JAMA Cardiology : 2020. Available from: URL: /link?doi=10.1001/jamacardio.2020.1834
Metadaten
Titel
Azithromycin/hydroxychloroquine/propofol
Hypoglycaemia and cardiotoxicities following off label use: 2 case reports
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80289-9

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Vaccines